Skip to main
NHI
NHI logo

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors Inc. has demonstrated financial strength by raising its normalized funds from operations (NFFO) estimates, with a new projection of $4.80 per share for 2025, which aligns with management's guidance range. Additionally, the company's 2026 FFO estimate has been adjusted upwards to $5.03 per share, surpassing the $5.00 consensus, signaling robust performance expectations. These upward revisions in key financial metrics reflect a positive outlook for the company's future growth and operational efficiency within its real estate and healthcare segments.

Bears say

National Health Investors Inc. faces a negative outlook due to expected lower earnings growth in the coming years, which stems from the interplay between accretive acquisition activities and potential operational challenges among its tenants. The company may encounter financial underperformance if the NHC rent reset falls short of investor expectations and if there are weaknesses in deferred rent collections, which could be exacerbated by potential future pandemic-related issues. Additionally, difficulties experienced by one or more operators could further impact the company’s revenue streams derived from rental income and other patient services.

NHI has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 5 analysts, NHI has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.